Table 2.
Univariate and multivariate analysis of prognostic factors of overall survival by Cox regression model
| Variable | Overall survival | |||
|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | |||
| HR (95% CI) | P value | HR (95% CI) | P value | |
| Age | 1.05 (1.03–1.07) | < 0.001 | 1.04 (1.01–1.07) | 0.005 |
| Gender (male) | 0.83 (0.48–1.41) | 0.483 | ||
| BMI | 1.34 (0.79–2.27) | 0.286 | ||
| Diabetes | 2.13 (1.19–3.78) | 0.010 | 1.08 (0.56–2.10) | 0.809 |
| CVD | 2.80 (1.32–5.94) | 0.007 | 0.87 (0.34–2.21) | 0.867 |
| Hypertension | 2.35 (1.28–4.31) | 0.006 | 1.10 (0.54–2.22) | 0.795 |
| Systolic pressure | 1.00 (0.99–1.01) | 0.862 | ||
| Diastolic pressure | 0.98 (0.96–1.00) | 0.080 | ||
| Total Kt/V | 1.16 (0.69–1.96) | 0.579 | ||
| Hemoglobin | 1.00 (0.99–1.01) | 0.805 | ||
| Albumin | 0.95 (0.89–1.02) | 0.135 | ||
| Creatinine | 1.05 (0.95–1.16) | 0.003 | 1.00 (0.99–1.00) | 0.178 |
| BUN | 0.97 (0.93–1.02) | 0.218 | ||
| Uric acid | 1.00 (1.00–1.00) | 0.642 | ||
| K | 1.01 (1.00–1.02) | 0.163 | ||
| Ca | 1.31 (0.55–3.11) | 0.547 | ||
| Na | 0.99 (0.98–1.00) | 0.251 | ||
| P | 0.86 (0.59–1.25) | 0.430 | ||
| iPTH | 0.99 (0.99–1.00) | 0.022 | 0.99 (0.99–1.00) | 0.021 |
| TC | 1.21 (0.99–1.48) | 0.066 | ||
| TG | 1.37 (1.21–1.56) | < 0.001 | 1.36 (1.17–1.58) | < 0.001 |
| HDL-C | 0.42 (0.19–0.92) | 0.030 | 0.27 (0.11–0.68) | 0.005 |
| LDL-C | 0.90 (0.71–1.40) | 0.990 | ||
| Non-HDL-C | 1.35 (1.10–1.66) | 0.005 | 1.23 (0.97–1.55) | 0.083 |
| TG/HDL-C | 3.56 (2.08–6.10) | < 0.001 | 3.57 (1.99–6.39) | < 0.001 |
| Non-HDL/HDL-C | 2.99 (1.65–5.44) | < 0.001 | 2.58 (1.39–4.81) | 0.003 |
| Therapy of Statin/Fibrate | 0.89 (0.72–1.21) | 0.079 | ||
CVD Cardiovascular disease, TG triglyceride, TC total cholesterol, BUN blood urea nitrogen, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol; iPTH, intact parathyroid hormone